When older adults with dementia are hospitalized, do they leave the hospital on more psychotropic meds than they come in on? And does this drive high rates of psychotropic use among ppl with dementia?
New study led by Matthew Growdon:
agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…
🧵
1/n
Rockstar deprescribing panel at #AGS22 with @zacharyamarcum Joshua Niznik, PharmD, PhD Matthew Growdon & Ariel Green of Johns Hopkins Geriatric Medicine & Gerontology! Some points: d/p takes mult visits, elicit what matters, frame d/p as + action.
Polypharmacy, deprescribing, where we are, and what we need to do to stop increasing medications for older adults and those living with serious illness. Guests Matthew Growdon, Anna Parks, and Mike Steinman.
Episode bit.ly/3el1bHt - hosts Alex Smith, MD | Eric Widera, MD
Congratulations Dr. Matthew Growdon for being awarded the Health in Aging Foundation New Investigator Award from the American Geriatrics Society (@AmerGeriatrics)! americangeriatrics.org/about-us/award… #geriatrics #research
You have taught us, inspired us, challenged us, and touched our souls. It will always be our greatest privilege to have been your chief residents. @BrighamChiefs Matthew Growdon Emily Lau, MD, MPH David Rubins Mounica Vallurupalli
If you missed this polypharmacy in older adults podcast with geriatricians Mike Steinman and Matthew E. Growdon, MD, MPH that covered some great topics around #deprescribing interventions + inappropriate #polypharmacy you can access the recording here: ow.ly/BePT50JG10O
Really interesting session on getting rid of fall risk-increasing drugs by Dr Ariel Green, Dr Joshua Niznik, PharmD, PhD, Dr Matthew Growdon and Dr @zacharyamarcum 💊💊💊
Many deprescribing opportunities are currently not taken advantage of!
#AGS2022 #deprescribing
Ugh. People with #dementia receive more drugs, including ones that are highly sedating. Matthew Growdon Mike Steinman JAGS US Deprescribing Research Network (USDeN)
agsjournals.onlinelibrary.wiley.com/doi/full/10.11…
Dr. Matthew Growdon gave an invited talk, 'Polypharmacy and Deprescribing in Older Adults with Dementia' at the National Academy of Neuropsychology national conference in Denver earlier this month. #geriatrics #hpm
Drs. Tem Bendapdudi and Matthew Growdon review the expected results of DAT in autoimmune hemolysis in a case of warm autoimmune hemolytic anemia.
'Attitudes toward deprescribing among older adults with dementia in the United States' (Matthew Growdon, Mike Steinman) - adds to our understanding of nuanced attitudes towards polypharmacy and deprescribing in people with dementia: agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…
Congratulations Dr. Matthew Growdon on receiving a two-year NIH-funded Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) Award! #geriatrics #research #ucsf @ucsf Read more: geriatrics.ucsf.edu/news/matthew-g…
Great piece of reporting by AARP on #COVID - thanks for including me! Always happy to advocate for #LifestyleMedicine , especially for patients 65+ (@LoewenthalMd Matthew Growdon).
💊Our latest #Deprescribing blog is about ' #Medication #Misuse & #Overuse in community dwelling persons w/ #Dementia '--new research by James Deardorff #BochengJing Matthew Growdon #kristineYaffe #JohnBoscardin #KennethBoockvar & Mike Steinman!
Check it out!➡️bit.ly/3YBygol
This week we are delighted to welcome Dr. Matthew Growdon (Matthew Growdon) to the UC San Francisco Division of Geriatrics faculty! Learn more about Dr. Growdon here: geriatrics.ucsf.edu/news/welcome-m… #geriatrics #ucsf
Belinda Tang, MSTAR student, Edie Espejo, MA, Drs. Mike Steinman, and Matthew Growdon published a research letter 'Cognitive, physical, and sensory deficits that can affect everyday medication use among older adults: A national view' in JAGS …nelibrary-wiley-com.ucsf.idm.oclc.org/doi/10.1111/jg…
